Real-Time Quantitative Analysis and Copy Number Assessment

Quantitative molecular methods measure how much of a target nucleic acid is present, rather than merely whether it is detectable. Real-time quantitative PCR tracks amplification as it happens, digital PCR partitions a sample to count molecules absolutely, and copy-number assessment determines whether a genomic region is gained or lost.

Definition

Real-time quantitative analysis measures the amount of a target nucleic acid, typically by monitoring fluorescent signal during amplification (real-time PCR) or by counting positive partitions (digital PCR); copy-number assessment determines the number of copies of a genomic region relative to a reference.

Scope

The topic covers real-time (quantitative) PCR, digital and droplet digital PCR, and approaches to copy-number assessment. It addresses the principles of quantification and the considerations that make results comparable, presented as methodological reference material rather than as clinical testing guidance.

Key concepts

• Real-time (quantitative) PCR
• Quantification cycle (Cq) and amplification efficiency
• Standard curves and relative quantification
• Digital and droplet digital PCR
• Absolute quantification by partitioning
• Copy-number gains and losses
• Reporting standards and reproducibility

Mechanisms

Real-time PCR couples amplification to a fluorescent reporter whose signal rises in proportion to product accumulation; the cycle at which signal crosses a threshold reflects the starting amount of target, allowing relative or standard-curve quantification (Heid et al., 1996). Digital PCR instead distributes the sample into many tiny partitions so that each contains zero or a few molecules; counting the fraction of positive partitions and applying Poisson statistics yields an absolute count without a standard curve (Hindson et al., 2011). Copy-number assessment compares the abundance of a target region against a reference to detect amplifications or deletions, an idea pioneered by comparative genomic hybridization (Kallioniemi et al., 1992).

Clinical relevance

Quantitative and copy-number methods are used to measure pathogen load, gene expression, and genomic gains or losses. This entry explains how quantification works as a methodological reference; it does not advise on selecting, interpreting, or acting on any specific quantitative assay in patient care.

Evidence & guidelines

Reporting of quantitative PCR is guided by the MIQE recommendations, which specify the minimum information needed for reproducible publication (Bustin et al., 2009). Foundational primary studies describe real-time quantification (Heid et al., 1996), absolute digital quantification (Hindson et al., 2011), and genome-wide copy-number measurement (Kallioniemi et al., 1992).

History

Real-time PCR in the mid-1990s turned amplification from a qualitative into a quantitative tool (Heid et al., 1996), and consensus reporting standards followed a decade later (Bustin et al., 2009). Digital PCR, and especially droplet digital PCR, then enabled absolute counting of molecules with high precision (Hindson et al., 2011), while copy-number assessment evolved from comparative genomic hybridization toward array- and sequencing-based methods (Kallioniemi et al., 1992).

Key figures

• Christian Heid
• Stephen Bustin
• Benjamin Hindson

Seminal works

• heid-1996
• hindson-2011
• bustin-2009

Frequently asked questions

How does digital PCR differ from real-time quantitative PCR?

Real-time PCR estimates the starting amount of target from how early the fluorescent signal crosses a threshold, usually relative to a standard, whereas digital PCR partitions the sample and counts positive compartments to give an absolute molecule count without a standard curve.

What does copy-number assessment measure?

It determines how many copies of a particular genomic region are present relative to a reference, identifying amplifications (gains) or deletions (losses) of that region.